SKYE - Skye Bioscience, Inc.

QQQ $ 604.92 $ 3.94 (0.66 %)

DIA $ 461.73 $ 2.22 (0.48 %)

SPY $ 665.28 $ 3.75 (0.57 %)

TLT $ 91.09 $ -0.14 (-0.15 %)

GLD $ 391.28 $ -7.46 (-1.88 %)

Previous Close

$ 1.38

Open

$ 1.45

Bid

$ 1.31 x 183

Ask

$ 1.54 x 34

Day's Range

$ 1.37 - $ 1.49

52 Week Range

$ 1.14 - $ 5.96

Volume

762,044

Average Volume

Market Cap

42.76M

Beta (5Y Monthly)

$ -19.66

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-07-2025	06-30-2025	10-Q
2	05-08-2025	03-31-2025	10-Q
3	03-20-2025	12-31-2024	10-K
4	11-07-2024	09-30-2024	10-Q
5	08-09-2024	06-30-2024	10-Q
6	05-10-2024	03-31-2024	10-Q
7	03-22-2024	12-31-2023	10-K
8	11-13-2023	09-30-2023	10-Q
9	08-07-2023	06-30-2023	10-Q
10	05-12-2023	03-31-2023	10-Q
11	03-31-2023	12-31-2022	10-K
12	11-14-2022	09-30-2022	10-Q
13	08-15-2022	06-30-2022	10-Q
14	05-06-2022	03-31-2022	10-Q
15	03-25-2022	12-31-2021	10-K
16	11-10-2021	09-30-2021	10-Q
17	08-06-2021	06-30-2021	10-Q
18	05-07-2021	03-31-2021	10-Q
19	03-02-2021	12-31-2020	10-K
20	11-06-2020	09-30-2020	10-Q
21	08-13-2020	06-30-2020	10-Q
22	05-08-2020	03-31-2020	10-Q
23	03-23-2020	12-31-2019	10-K
24	11-14-2019	09-30-2019	10-Q
25	08-09-2019	06-30-2019	10-Q
26	05-09-2019	03-31-2019	10-Q
27	03-14-2019	12-31-2018	10-K
28	11-14-2018	09-30-2018	10-Q
29	08-10-2018	06-30-2018	10-Q
30	05-15-2018	03-31-2018	10-Q
31	03-19-2018	12-31-2017	10-K
32	11-14-2017	09-30-2017	10-Q
33	08-11-2017	06-30-2017	10-Q
34	05-12-2017	03-31-2017	10-Q
35	03-10-2017	12-31-2016	10-K
36	11-09-2016	09-30-2016	10-Q
37	08-12-2016	06-30-2016	10-Q
38	05-13-2016	03-31-2016	10-Q
39	03-21-2016	12-31-2015	10-K
40	11-12-2015	09-30-2015	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

nasdaq-jumps-over-150-points-skye-bioscience-shares-plunge

Nasdaq Jumps Over 150 Points; Skye Bioscie...
10/06/2025 17:09:01

12 Health Care Stocks Moving In Monday's I...
10/06/2025 17:07:04

US Stocks Mixed; Dow Falls 100 Points
10/06/2025 15:05:56

skye-biosciences-investigational-drug-disappoints-as-monotherapy-for-weight-loss

Skye Bioscience's Investigational Drug Dis...
10/06/2025 14:39:32

Skye Bioscience'a trial showed nimacimab alone missed goals, while a combo with Novo Nordisk's drug delivered stronger ...

why-amd-shares-are-trading-higher-by-over-34-here-are-20-stocks-moving-premarket

Why AMD Shares Are Trading Higher By Over ...
10/06/2025 13:01:08

12 Health Care Stocks Moving In Monday's P...
10/06/2025 12:08:40

Skye Bioscience Released Topline Data From...
10/06/2025 11:07:50

In CBeyond, the nimacimab monotherapy arm did not achieve the primary endpoint of weight loss compared to placebo (-1.52% vs. -...

HC Wainwright & Co. Initiates Coverage On ...
09/30/2025 11:22:51

HC Wainwright & Co. analyst Ananda Ghosh initiates coverage on Skye Bioscience (NASDAQ:SKYE) with a Buy rating and annou...

12 Health Care Stocks Moving In Friday's A...
09/26/2025 21:06:04

Gainers Enanta Pharma (NASDAQ: ENTA) stock rose 15.6% to $9.13 during Friday's after-market session. The market value of t...

could-this-new-drug-be-the-safer-way-to-fight-obesity

Could This New Drug Be The Safer Way To Fi...
09/19/2025 18:19:20

Skye Bioscience reported favorable Phase 1b nimacimab results, with analysts citing strong potential in obesity alongside GLP-1...

Skye Presents Phase 1b Data Showing Nimaci...
09/19/2025 11:04:08

skye-bioscience-advances-position-in-competitive-obesity-market-with-promising-data

Skye Bioscience Advances Position In Compe...
09/05/2025 17:35:17

Skye Bioscience's latest data show nimacimab boosted tirzepatide's weight loss effects and reduced obesity treatment re...

Skye's Nimacimab Boosts Tirzepatide Result...
09/04/2025 11:10:13

Skye Bioscience, Inc. (NASDAQ:SKYE) ("Skye"), a clinical-stage biotechnology company focused on unlocking new therapeut...

Skye Bioscience Announces Completion Of 26...
09/02/2025 11:03:43

Evercore ISI Group Initiates Coverage On S...
08/15/2025 17:52:42

Evercore ISI Group analyst Michael DiFiore initiates coverage on Skye Bioscience (NASDAQ:SKYE) with a Outperform rating and ...

Skye Bioscience Q2 EPS $(0.44) Misses $(0....
08/07/2025 20:45:06

Skye Bioscience (NASDAQ:SKYE) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate of $(0...

Earnings Scheduled For August 7, 2025
08/07/2025 08:33:15

JMP Securities Reiterates Market Outperfor...
06/24/2025 13:47:38

JMP Securities analyst Jonathan Wolleben reiterates Skye Bioscience (NASDAQ:SKYE) with a Market Outperform and maintains $15...

12 Health Care Stocks Moving In Monday's I...
06/23/2025 17:06:33

Skye Bioscience Showcases Anti-Obesity Dru...
06/23/2025 11:14:37

Skye Bioscience, Inc. (NASDAQ:SKYE) ("Skye"), a clinical-stage biotechnology company focused on unlocking new therapeut...